Advertisement

Chronic Cough: Evaluation of Patients' Success in Completing Cough Suppression Therapy

Published:October 28, 2022DOI:https://doi.org/10.1016/j.jvoice.2022.09.022

      Summary

      Background

      Chronic cough is highly prevalent amongst many patients in the US. Behavioral interventions with speech-language pathologists (SLP) can improve quality of life but require patient-centered motivation, therapy attendance, and compliance with therapy techniques. Previous studies have shown the internal factors of self-efficacy and goal commitment are integral to patient motivation to pursue cough suppression therapy (CST). In this observational study, the authors aim to identify the motivational factors that prompt patients’ progression from the contemplation to action stage of change and attend cough suppression therapy.

      Methods

      A retrospective chart review was performed on patients > 18 years presenting to a tertiary care laryngology clinic with chronic cough. The patients were previously surveyed between February 2021-July 2021 to determine motivational factors for attending CST. Patient compliance with CST was identified (yes/no) as well as the number of visits and cough severity index (CSI) at therapy, if available.

      Results

      Thirty-five patients were identified with ages ranging from 33-76 (mean 57.6 years, SD: 12.3). The majority were female (n=25) with a mean presenting CSI of 19.9 (10.3). After expressing intent, 71% of patients entered the action phase of change and attended CST with an average improvement in CSI of 4.4.

      Conclusion

      The most common motivational factors overall were cough bothersome to self and desire for cough to improve, however, the extrinsic motivation of cough bothersome to others was more often reported by those attending therapy. Understanding patients’ motivations to participate in CST may be useful when assessing candidacy and helping patients remain in the action stage required for success in behavioral therapy.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Visca D
        • Beghè B
        • Fabbri LM
        • et al.
        Management of chronic refractory cough in adults.
        Eur J Intern Med. 2020; 81: 15-21https://doi.org/10.1016/j.ejim.2020.09.008
        • Chung KF
        • Pavord ID.
        Prevalence, pathogenesis, and causes of chronic cough.
        Lancet. 2008; 371: 1364-1374https://doi.org/10.1016/S0140-6736(08)60595-4
        • Morice AH
        • Fontana GA
        • Sovijarvi AR
        • et al.
        The diagnosis and management of chronic cough.
        Eur Respir J. 2004; 24 (or Morice AH, McGarvey L, Pavord I, Group BTSCG (2006) Recommendations for the management of cough in adults. Thorax 61(Suppl 1):i1–24): 481-492https://doi.org/10.1183/09031936.04.00027804
        • Ford AC
        • Forman D
        • Moayyedi P
        • et al.
        Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms.
        Thorax. 2006; 61: 975-979
        • Brignall K
        • Jayaraman B
        • Birring SS
        Quality of life and psychosocial aspects of cough.
        Lung. 2008; 186: S55-S58
        • Chamberlain S
        • Birring SS
        • Garrod R.
        Nonpharmacological interventions for refractory chronic cough patients: systematic review.
        Lung. 2014; 192: 75-85https://doi.org/10.1007/s00408-013-9508-y
        • Haque RA
        • Usmani OS
        • Barnes PJ.
        Chronic idiopathic cough: a discrete clinical entity?.
        Chest. 2005; 127: 1710-1713https://doi.org/10.1378/chest.127.5.1710
        • Ryan NM
        • Birring SS
        • Gibson PG.
        Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.
        Lancet. 2012; 380: 1583-1589https://doi.org/10.1016/S0140-6736(12)60776-4
        • Vertigan AE
        • Kapela SL
        • Ryan NM
        • et al.
        Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial.
        Chest. 2016; 149: 639-648https://doi.org/10.1378/chest.15-1271
        • Dicpinigaitis PV
        • Dobkin JB.
        Antitussive effect of the GABA-agonist baclofen.
        Chest. 1997; 111: 996-999https://doi.org/10.1378/chest.111.4.996
        • Norris BK
        • Schweinfurth JM.
        Management of recurrent laryngeal sensory neuropathic symptoms.
        Ann Otol Rhinol Laryngol. 2010; 119: 188-191https://doi.org/10.1177/000348941011900307
        • Dhillon VK.
        Superior laryngeal nerve block for neurogenic cough: a case series.
        Laryngoscope Investig Otolaryngol. 2019; 4: 410-413
        • Slovarp LJ
        • Jetté ME
        • Gillespie AI
        • et al.
        Evaluation and management outcomes and burdens in patients with refractory chronic cough referred for behavioral cough suppression therapy.
        Lung. 2021; 199: 263-271https://doi.org/10.1007/s00408-021-00442-w
        • LaTour D
        • Crawley B
        • Krishna P
        • et al.
        Effects of cough suppression therapy on voice disorder severity.
        Laryngoscope. 2021; 131: 2747-2751https://doi.org/10.1002/lary.29705
        • Wright ML
        • Sundar KM
        • Herrick JS
        • et al.
        Long-term treatment outcomes after behavioral speech therapy for chronic refractory cough.
        Lung. 2021; 199: 517-525https://doi.org/10.1007/s00408-021-00481-3
        • Prochaska JO
        • Velicer WF.
        The transtheoretical model of health behavior change.
        Am J Health Promot. 1997; 12: 38-48https://doi.org/10.4278/0890-1171-12.1.38
        • Raihan N
        • Cogburn M.
        Stages of change theory.
        StatPearls. StatPearls Publishing, Treasure IslandFL2022 (March 9)
        • Rao SJ
        • Ruckart KW
        • Nosow LM
        • et al.
        Chronic cough: evaluation of patients' motivation to undergo cough suppression therapy [published online ahead of print, 2022 Mar 9].
        J Voice. 2022; (S0892-1997(22)00033-9)https://doi.org/10.1016/j.jvoice.2022.02.007
        • Madden LL
        • Hernandez BO
        • Russell GB
        • et al.
        The demographics of patients presenting for laryngological care at an academic medical center.
        Laryngoscope. 2021; 132: 626-632https://doi.org/10.1002/lary.29831
        • Slovarp L
        • Loomis BK
        • Glaspey A.
        Assessing referral and practice patterns of patients with chronic cough referred for behavioral cough suppression therapy.
        Chron Respir Dis. 2018; 15: 296-305https://doi.org/10.1177/1479972318755722
        • van Leer E
        • Hapner ER
        • Connor NP.
        Transtheoretical model of health behavior change applied to voice therapy.
        J Voice. 2008 Nov; 22 (Epub 2007 Dec 21. PMID: 18082367; PMCID: PMC2904548): 688-698https://doi.org/10.1016/j.jvoice.2007.01.011
        • Batool-Anwar S
        • Baldwin CM
        • Fass S
        • et al.
        Role og spousal involvement in continuous positive airway pressure (CPAP) adherence in patients with obstructive sleep apnea (OSA).
        Southwest J Pulm Crit Care. 2017; 14 (MayEpub 2017 May 8PMID: 28725492; PMCID: PMC5512877): 213-227https://doi.org/10.13175/swjpcc034-17